HomeCompareBASX vs ABBV

BASX vs ABBV: Dividend Comparison 2026

BASX yields 3333.33% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BASX wins by $1244041712890.30M in total portfolio value
10 years
BASX
BASX
● Live price
3333.33%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1244041712890.40M
Annual income
$1,174,716,366,071,938,000.00
Full BASX calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — BASX vs ABBV

📍 BASX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBASXABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BASX + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BASX pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BASX
Annual income on $10K today (after 15% tax)
$283,333.33/yr
After 10yr DRIP, annual income (after tax)
$998,508,911,161,147,300.00/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, BASX beats the other by $998,508,911,161,126,100.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BASX + ABBV for your $10,000?

BASX: 50%ABBV: 50%
100% ABBV50/50100% BASX
Portfolio after 10yr
$622020856445.25M
Annual income
$587,358,183,035,981,400.00/yr
Blended yield
94.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

BASX
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BASX buys
0
ABBV buys
0
No recent congressional trades found for BASX or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBASXABBV
Forward yield3333.33%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.6%
Portfolio after 10y$1244041712890.40M$102.3K
Annual income after 10y$1,174,716,366,071,938,000.00$24,771.77
Total dividends collected$1239274250481.68M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: BASX vs ABBV ($10,000, DRIP)

YearBASX PortfolioBASX Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$344,033$333,333.33$11,550$430.00+$332.5KBASX
2$11,085,665$10,717,549.33$13,472$627.96+$11.07MBASX
3$334,616,633$322,754,971.08$15,906$926.08+$334.60MBASX
4$9,462,934,690$9,104,894,892.71$19,071$1,382.55+$9462.92MBASX
5$250,766,259,005$240,640,918,887.41$23,302$2,095.81+$250766.24MBASX
6$6,228,082,462,189$5,959,762,565,053.11$29,150$3,237.93+$6228082.43MBASX
7$144,998,525,500,125$138,334,477,265,582.72$37,536$5,121.41+$144998525.46MBASX
8$3,165,074,899,913,431$3,009,926,477,628,297.00$50,079$8,338.38+$3165074899.86MBASX
9$64,790,043,755,570,470$61,403,413,612,663,110.00$69,753$14,065.80+$64790043755.50MBASX
10$1,244,041,712,890,398,500$1,174,716,366,071,938,000.00$102,337$24,771.77+$1244041712890.30MBASX

BASX vs ABBV: Complete Analysis 2026

BASXStock

Basic Energy Services, Inc. provides wellsite services to oil and natural gas drilling and producing companies in the United States. Its Well Servicing segment provides services performed with a mobile well servicing rig and ancillary equipment, such as maintenance work involving removal, repair, and replacement of down-hole equipment; hoisting tools and equipment required by the operation into and out of the well, or removing equipment from the well bore; and plugging and abandonment services, as well as manufactures and sells workover rigs. As of December 31, 2019, this segment operated a fleet of 306 well servicing rigs. The company's Water Logistics segment provides oilfield fluid supply, transportation, storage, and midstream services, such as the operation of company-owned fresh water and brine source wells and of non-hazardous wastewater disposal wells; sale and transportation of fresh and brine water; transportation of fluids used in drilling, completion, workover, and flowback operations and of saltwater produced as a by-product; rental of portable fracturing tanks and test tanks; recycling and treatment of wastewater, including produced water and flowback; and preparation, construction, and maintenance of access roads, drilling locations, and production facilities. This segment owned and operated 762 fluid service trucks with an average fluid hauling capacity of up to 150 barrels; and owned 87 saltwater disposal wells. Its Completion & Remedial Services segment offers services, including rental and fishing tools; coiled tubing; snubbing services; thru-tubing; and underbalanced drilling in low pressure and fluid sensitive reservoirs. This segment operates 24 air compressor packages, 32 snubbing units, and 9 coiled tubing units. The company was formerly known as Sierra Well Service, Inc. and changed its name to Basic Energy Services, Inc. in 2000. Basic Energy Services, Inc. was founded in 1992 and is headquartered in Fort Worth, Texas.

Full BASX Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this BASX vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BASX vs SCHDBASX vs JEPIBASX vs OBASX vs KOBASX vs MAINBASX vs JNJBASX vs MRKBASX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.